Panacea Biotec reports net loss of Rs 82.75 crore in the March 2013 quarter
Capital MarketNet Loss of Panacea Biotec reported to Rs 82.75 crore in the quarter ended March 2013 as against net loss of Rs 119.15 crore during the previous quarter ended March 2012. Sales rose 104.90% to Rs 184.37 crore in the quarter ended March 2013 as against Rs 89.98 crore during the previous quarter ended March 2012.
For the Audited full year,net loss reported to Rs 230.13 crore in the year ended March 2013 as against net loss of Rs 207.80 crore during the previous year ended March 2012. Sales declined 22.95% to Rs 530.42 crore in the year ended March 2013 as against Rs 688.38 crore during the previous year ended March 2012.
ParticularsQuarter EndedYear EndedMar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.Sales184.3789.98
105 530.42688.38
-23 OPM %-16.28-69.92
77 -13.69-7.52
-82 PBDT-61.73-108.15
43 -172.92-145.43
-19 PBT-82.75-127.82
35 -256.46-220.82
-16 NP-82.75-119.15
31 -230.13-207.80
-11 Powered by Capital Market - Live News